ACBM — what changed in the latest 10-Q
A section-by-section comparison of ACBM's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-05 vs the prior 10-Q · 2025-11-10
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +7 | −9 | ~4 | 12 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~3 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-05
The following table summarizes our changes in working capital from December 31, 2025 to March 31, 2026:
The following table summarizes our cash flows for the three months ended March 31, 2026 and 2025:
Cash used in operating activities of $49,821 for the three months ended March 31, 2026 reflected primarily our net loss of $43,774 increased by imputed interest of $3,503 and prepaid expense of $10,000 and reduced by liability extinguishment of $20,000.
Cash used in operating activities of $22,531 for the three months ended March 31, 2025 reflected primarily our net loss of $10,301, reduced by decreases in accounts payable and accrued expenses $11,282 and operating lease liability of $2,315 and increased by imputed interest of $1,367.
Cash provided by financing activities for the three months ended March 31, 2026 and 2025 reflected advances from a minority stockholder. These advances provided us with funds to cover our cash used in operations.
Text removed vs the prior filing · source: 10-Q · 2025-11-10
For the nine months ended September 30, 2025, we had no revenue or cost of revenue. Our operating expenses were $137,647, which are primarily related to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $6,025. A…
For the nine months ended September 30, 2024, we had no revenue or cost of revenue. Our operating expenses were $28,490, which are primarily relating to expenses and professional fees relating to our status as a public company. We also incurred interest expense to a minority stockholder of $3,134. A…
The following table summarizes our changes in working capital from December 31, 2024 to September 30, 2025:
The following table summarizes our cash flows for the nine months ended September 30, 2025 and 2024:
Cash used in operating activities of $170,925 for the nine months ended September 30, 2025 reflected primarily our net loss of $143,672 reduced by a decrease in accounts payable and accrued expenses of $35,563 and increased by imputed interest – related parties of $6,025 and security deposit of $2,2…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice